1006 / 1851
RTOG 0617 Trial
Overall Survival
Bradley JD. et al. Lancet Oncol 2015;16
Median survival time:
28.7 vs 20.3 months
p = 0.004
N.B.
Local failure rates at 18 months:
•
25.1% in standard arm (60 Gy)
•
34.3% in high dose arm (74 Gy)
p < 0.05